Evaluation of the Effectiveness of the HPV Education Program Applied to Women

March 15, 2026 updated by: Özlem Akgöl, Okan University

Evaluation of the Effectiveness of a Nursing Education Program on "HPV and Its Effects on Women's Health" Applied to Women of Reproductive Age

This study aimed to evaluate the effectiveness of an educational program conducted by nurses on Human Papilloma Virus and its effects on women's health in women of reproductive age. Data were collected from women aged 30-49 with active sexual lives using a Descriptive Information Form and the HPV Knowledge Scale, and then analyzed and interpreted.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This study used randomized experimental and control groups in its design. Participants were women with active sexual lives who visited a Family Health Center in Istanbul for three months. Sample size was determined using power analysis. Women in the experimental group participated in a nursing education program titled "HPV and its Effects on Women's Health." Written informed consent was obtained from the participants. A pre-test was administered to all participants. Following the baseline assessment, participants in the experimental group participated in a nurse-led education program prepared by the researcher. The program focused on HPV transmission, prevention methods, vaccination, screening, and its effects on women's health. Participants in the control group did not receive any educational intervention at this stage. One month after the completion of the training, post-tests were administered to both groups. The assessment tools used were as follows: Women's sociodemographic characteristics, participation in health screenings, and HPV-related characteristics were recorded on an Information Form. Women's knowledge level about HPV was measured using the HPV Knowledge Scale. The scale consisted of 33 items and 2 sub-dimensions. The first sub-dimension of the scale is scored between 0 and 16. Higher scores indicate a higher level of general knowledge about HPV. The second subdimension measures the level of knowledge about the HPV vaccination program. The total score obtainable from this subdimension ranges from 0 to 6. Higher scores indicate a higher level of knowledge about HPV vaccination.

Study Type

Interventional

Enrollment (Actual)

84

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Istanbul
      • Tuzla, Istanbul, Turkey (Türkiye), 34843
        • Istanbul Okan University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Sampling Inclusion Criteria:

Female individuals Having been diagnosed with HIV Being between 18-49 years of age Being sexually active

Sampling Exclusion Criteria:

  • Being pregnant
  • Being postpartum
  • Disabled individuals
  • Individuals whose gender identity does not match their biological sex at birth, those receiving hormonal therapy, or other conditions that do not fit the specific biological focus of the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Education Group
This group will be trained using Pender's Health Promotion Model.
Behavioral: Reproductive health education program
Reproductive health education program prepared using Pender's Health Promotion Model.
No Intervention: Control
This group will not receive training; only assessments will be conducted.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
"Scale for Determining the Reproductive Health Preventive Attitudes of Married Women"
Time Frame: Up to 6 months
The Reproductive Health Protective Attitudes Scale for Married Women is a Likert-type scale consisting of 39 items, scored from 1 to 5. The total raw score obtained by summing the 39 items ranges from 39 to 195. It has five sub-dimensions. Higher total and sub-dimension scores indicate more positive attitudes and behaviors towards protecting women's reproductive health.
Up to 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Okan University

Investigators

  • Principal Investigator: Ozlem Akgol, Asst. Professor, Okan University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 25, 2024

Primary Completion (Actual)

September 25, 2024

Study Completion (Actual)

January 14, 2025

Study Registration Dates

First Submitted

February 13, 2026

First Submitted That Met QC Criteria

March 9, 2026

First Posted (Actual)

March 12, 2026

Study Record Updates

Last Update Posted (Actual)

March 17, 2026

Last Update Submitted That Met QC Criteria

March 15, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 10.01.2024/172

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on HIV (Human Immunodeficiency Virus)

Clinical Trials on Reproductive health education program

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe